Fri. 24 May 2024, 7:02am ET
Benzinga
News
- New analysis of biopsy samples demonstrated a significant increase in CD8+ T-cell density in tumors from all 11 patients treated
- 7 of 11 patients in the pilot phase experienced a partial response, with 6 confirmed; 10 of 11 patients experienced disease control
- Poster Presentation on Saturday, June 1, 2024 in Chicago, Illinois